BioLargo Inc. (BLGO:OTCQX) recently validated key performance metrics for its Cellinity battery technology, designed to address long-duration energy storage needs. Through preliminary testing, the company confirmed the stability, reliability, and efficiency of Cellinity’s chemistry. These tests verified the battery’s performance claims, showing its ability to hold a charge without self-discharging and to charge and discharge quickly at high voltage. BioLargo also noted plans for further testing at third-party facilities to validate additional aspects of Cellinity’s electrochemical performance.
Dennis P. Calvert, President and CEO of BioLargo, emphasized the technology’s significance in the press release, referencing a recent Economist article projecting global energy storage needs to rise from 200 gigawatts today to over five terawatts by 2050. Calvert remarked, “We’re very excited about the future of this important battery technology.” He added that Cellinity’s safety, lifespan, and energy density make it well-positioned to contribute to the global energy transition.
Powering the Future with Grid-Scale Storage
As the Financial Times noted in October, “Renewable energy capacity [had] been added to the world’s energy systems at the fastest rate in two decades,” with the International Energy Agency (IEA) raising its forecast for 2027 by 33 percent. This growth trajectory depended heavily on battery storage solutions like grid-scale battery energy storage systems (BESS), essential for stabilizing fluctuating power from renewable sources and bolstering grid resilience. Projections estimated the BESS market to reach US$150 billion by 2030.
The IEA highlighted the increasing importance of battery storage in managing grid stability as renewable deployment expanded. According to their report, “Grid-scale storage, particularly batteries, [was] essential to manage the impact on the power grid and handle the hourly and seasonal variations in renewable electricity output,” supporting a stable energy supply while meeting rising demand. The IEA also emphasized the scalability of batteries for deployment across various applications, reflecting BioLargo’s Cellinity battery technology’s relevance to grid-scale needs.
In September, Forbes pointed out that “batteries [were] now the fastest-growing secondary electricity source for the grid,” largely due to rapid gains in renewable power sources like wind and solar, which experienced a record increase in solar capacity in the second quarter of 2024. As BioLargo continues developing its Cellinity platform, this growth reinforced the relevance of advanced storage technologies to facilitate efficient power management and to meet the projected demand for low-emission solutions.
Biolargo Catalysts
According to their website, BioLargo’s Cellinity battery technology marks a pivotal development in energy storage, offering a safer, more sustainable, and higher-density alternative to traditional lithium-ion batteries. Designed for grid-scale storage, renewable energy, and electric vehicle charging applications, Cellinity is tailored to meet increasing global demand for reliable, long-duration energy storage. With performance metrics validated through internal testing, the battery's non-venting, sealed-cell design and absence of self-discharging position it as a dependable solution in commercial and industrial contexts.
The company’s forward-looking strategy includes upcoming third-party validation at accredited facilities to further verify Cellinity's electrochemical performance, adding credibility to the product’s market potential. Additionally, BioLargo is developing larger format ‘Spartan’ Cellinity cells and modular battery units, a move expected to facilitate easier integration into diverse energy systems. This combination of ongoing testing, unique technical specifications, and scalable design indicates BioLargo’s commitment to seizing opportunities in a battery storage market projected to reach between US$200 billion and US$700 billion by 2030, fueled by global clean energy initiatives.
Ownership and Share Structure
Streetwise Ownership Overview*About 14.6% of BioLargo is owned by insiders and management, according to Yahoo! Finance. They include Chief Science Officer Kenneth Code with 8.44%, CEO Calvert with 3.32%, and Director Jack Strommen with 1.64%, Reuters reported.
About 0.04% is held by the institution First American Trust, Reuters said.
The rest, about 85%, is retail.
Its market cap is US$75.15 million, with about 296.84 million shares outstanding and about 254.71 million free-floating. It trades in a 52-week range of US$0.45 and US$0.16.
| Want to be the first to know about interesting Clean Energy investment ideas? Sign up to receive the FREE Streetwise Reports' newsletter. | Subscribe |
Important Disclosures:
Important Disclosures:
- BioLargo Inc. is a billboard sponsor of Streetwise Reports and pays SWR a monthly sponsorship fee between US$4,000 and US$5,000.
- As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of BioLargo Inc.
- James Guttman wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
For additional disclosures, please click here.
